Preliminary assessment of interand intraobserver reproducibility, and normative values of renal mean transit time (MTT) and parenchymal transit time (PTT) for 99mTc-etylenodicysteine by Cichocki, Paweł et al.
29
Nuclear Medicine Review 2015, 18, 1: 29–34
DOI: 10.5603/NMR.2015.0007




Correspondence to: Paweł Cichocki




Preliminary assessment of inter-  
and intraobserver reproducibility,  
and normative values of renal mean  
transit time (MTT) and parenchymal  
transit time (PTT) for 99mTc-etylenodicysteine
Paweł Cichocki1, Marian Surma1, Wojciech Woźnicki1, Małgorzata Bieńkiewicz2, Anna Płachcińska2, Jacek Kuśmierek1
1Department of Nuclear Medicine, Medical University of Łódź, Poland
2Department of Quality Control and Radiological Protection, Medical University of Łódź, Poland
[Received 31 X 2014; Accepted 07 I 2015]
Abstract
BACKGROUND: The clinical significance of MTT and PTT, determined by deconvolution of renographic curves, is arguable. 
Their usefulness in diagnosis of obstructive uro- and nephropathy, renovascular hypertension and monitoring of transplanted 
kidneys is pointed out, but susceptibility of deconvolution methods to errors resulting from “statistical noise” is also stressed. 
So far there are no reports on normative MTT values for 99mTc-EC, although such values were already determined for 131I-OIH, 
99mTc-DTPA and 99mTc-MAG3. The aim of this study is an assessment of inter- and intraobserver reproducibility of MTT and PTT 
for 99mTc-EC, and determination of normative values for these parameters.
MATERIALS AND METHODS: 31 patients (17 women and 14 men aged 19–75, average 44 years) referred for dynamic renal 
scintigraphy with: unilateral flow impairment (11), unilateral nephrolithiasis (2), control after unilateral lithotripsy (4), moderate 
hypertension (demographically with > 99% probability of primary hypertension) (4), suspected cirrhosis of one kidney (3), 
future kidney donors (3), control after abdominal injuries (3), incontinence (1).
42 functionally efficient kidneys were included in the study. Criteria for recognition of a kidney as functionally efficient were: 
— no earlier history of renal disease, signs of renal damage in basic blood and urine tests, or abnormalities in ultrasonography; 
— normal result of dynamic renal scintigraphy (in terms of sequential images and renographic curve).
MTT and PTT values were determined independently by two operators, using a matrix method for deconvolution of renographic 
curves.
RESULTS: Differences between mean MTT and PTT from two studies by one operator were insignificant and those values 
were closely correlated (r = 0.99 and r = 0.97, respectively). Differences of values obtained by both operators were practi-
cally insignificant for MTT (r = 0.93), and significant for PTT (r = 0.81 and p < 0.001). These differences do not disqualify that 
processing method. The upper limits of normative values of MTT and PTT were based on the results from first study performed 
by more experienced operator — 200 s and 170 s, respectively.
CONCLUSIONS: The procedure of processing dynamic renal scintigraphy used in this study is reproducible. Normative values 
of MTT and PTT for 99mTc-EC were established as 200 s and 170 s, respectively. An attempt to optimize and standardize the 
technique of determining parenchymal ROI in a matrix deconvolution method, followed by an evaluation of clinical usefulness of 
these parameters in the diagnosis of chosen renal function impairments would be a logical continuation of this initial research.
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Complexity of the renal function makes it difficult to cover 
its whole range with a single diagnostic procedure. Scintigraphic 
methods are limited to the assessment of the two arbitrary renal 
functions. Those are: “uptake function”, that is the ability of a kidney 
to absorb a specific radiopharmaceutical from the bloodstream and 
“transit function”, that is the ability to transport an absorbed tracer 
through the kidney parenchyma to the urinary tract. Dynamic renal 
scintigraphy, used for many years in the diagnosis of the condition 
of kidneys, allows the assessment of both of these functions using 
radiopharmaceuticals such as 131I-OIH, 99mTc-DTPA, 99mTc-MAG3 and 
the most recently introduced — 99mTc-EC.
Dynamic renal scintigraphy allows the evaluation of these func-
tions based on a qualitative assessment of sequential scintigraphic 
images and the shape of the renographic curves. Additionally, 
basic quantitative parameters are also calculated — the relative 
participation of each kidney in their overall function (split function) 
and times: of achieving maximum activity of the radiopharmaceuti-
cal in the kidney — Tmax and decrease of that activity to half of the 
maximum — T1/2. Some other quantitative parameters are also 
used, for example: ratio of activity in the kidney in the 20th minute to 
maximum activity (R20/max), or to activity in the 3rd minute (R20/3), 
or the ratio of the maximum activity to activity in the 890th second 
(ER — excretion ratio) [1–3]. For a more thorough analysis of the 
function of each kidney and urinary tract, parametric images of renal 
clearance function [4–6], ureteral peristalsis [7] and others [8–10] are 
also generated. Moreover, after processing of the scintigraphic data, 
additional parameters concerning the transport of the radiopharma-
ceutical through the entire kidney — MTT (Mean Transit Time) and 
its parenchyma — PTT (Parenchymal Transit Time), can be obtained.
MTT and PTT can have an important role in the diagnosis of 
obstructive uro- and nephropathy [11, 12], renovascular hyperten-
sion [12–14] and in monitoring the function of the transplanted 
kidney [15, 16]. The most common methods used to determine 
the values of these parameters are based on the deconvolution of 
renographic curves and blood activity curve. Some authors, how-
ever, point out an uncertainty of the time parameters calculated by 
deconvolution, caused by a susceptibility of the impulse response 
function to the noise from the stochastic nature of radioactive 
decay and radiation detection [17, 18]. For that reason, Rutland et 
al. [19] and Sámal et al. [20] presented methods for determining 
MTT and PTT not relying on deconvolution of renographic curves. 
According to Fleming’s comparative analysis of these param-
eters determined by means of deconvolution and a method based 
on Rutland’s theory their similar usefulness for the calculation of 
renal transit time parameters has been shown [21]. On the other 
hand, the method proposed by Sámal et al. [20] based on factor 
analysis, requires the acquisition of sequential images in short time 
intervals, which in turn requires administering the patient higher 
activity of the radiopharmaceutical. Therefore, MTT and PTT are 
most frequently measured with deconvolution methods based on 
the matrix algorithm or Fourier transformation [21–23].
It is expected that MTT and PTT determination techniques, 
as well as other research methods, meet the requirements of 
inter- and intraobserver reproducibility. Therefore, in this study, 
these values for the procedure based on the matrix deconvolution 
algorithm were evaluated.
The upper limit of normative values of MTT and PTT is also 
considerably significant (lower limit is not taken into account, since 
shorter transit time through kidneys is not important from a clini-
cal point of view). Such values were determined for 131I-OIH [24], 
99mTc-DTPA [25–27] and for 99mTc-MAG3 [3, 28], both based on 
groups of healthy volunteers as well as patients with kidneys consi-
dered as functionally efficient. So far there are no reliable normative 
values of MTT and PTT for 99mTc-EC. Gupta et al. [29] only deter-
mined the value of PTT, but just on a group of five healthy volunteers. 
Among nephrothropic radiopharmaceuticals, 99mTc-EC has fa-
vourable pharmacological properties (a high extraction rate), which 
make it especially useful and applicable for dynamic renal scin-
tigraphy [30–32]. However, different renal extraction mechanism 
of 99mTc-EC than of 99mTc-DTPA and 99mTc-MAG3, and different 
proportions of its filtration and secretion than of 123/131I-OIH, make 
it necessary to determine separate normative values of MTT and 
PTT for these radiopharmaceuticals.
The purpose of this study is to evaluate the inter- and intraob-
server reproducibility of the procedure, and determine normative 
values of MTT and PTT for 99mTc-EC. 
Materials and methods
Dynamic renal scintigraphies performed at our department 
in years 2011–2013 were analysed retrospectively. Kidneys were 
considered functionally efficient based on the following criteria: 
 — patients had routine urinalysis within normal limits and blood 
levels of urea and creatinine within normal ranges according 
to the reference values provided by the laboratory; 
 — they had no history of any diseases of the urinary tract or the 
selected kidney; 
 — in ultrasound, selected kidneys were typically located and 
had normal shapes and sizes. There were no signs of dilated 
pelvis or calices, cysts, cortical defects, or other morphological 
abnormalities; 
 — the result of dynamic renal scintigraphy of the selected kidney 
in terms of sequential images and renographic curve, assessed 
independently by two physicians, was normal (that includes the 
split function of the kidney ≥ 45%, Tmax ≤ 300 s and T1/2 ≤ 600 s).
Based on the above criteria, 42 kidneys regarded as function-
ally efficient were selected in 31 patients — 17 women and 14 men 
aged 19–75 years (44 years on average).
Those patients were referred for dynamic renal scintigraphy with: 
 — suspected unilateral outflow impairment (all confirmed impair-
ments were minor and did not require a diuretic test — 11 pa-
tients) (only contralateral kidney was selected); 
 — suspected unilateral nephrolithiasis (2 patients) (only contralat-
eral kidney was selected); 
 — control after unilateral lithotripsy (no sooner than 1 year after 
therapy — 4 patients) (only contralateral kidney was selected); 
 — moderate, freshly diagnosed hypertension, demographically 
with > 99% probability of primary hypertension (study without 
captopril — 4 patients) (both kidneys were selected); 
 — suspected cirrhosis of one of the kidneys (excluded after 
renal scintigraphy — 3 patients) (only contralateral kidney 
was selected); 
 — qualification of future kidney donors (3 patients) (both kid-
neys were selected); 
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 — control after abdominal injuries (any damage to the kid-
neys was excluded by morphological and scintigraphic evalu-
ation — 3 patients) (both kidneys were selected); 
 — incontinence (1 patient) (both kidneys were selected).
In all patients, dynamic renal scintigraphy was carried out ac-
cording to the standard protocol without a diuretic test. Each patient 
approx. 1/2 h before the test was recommended to drink 500 ml of 
water and empty the bladder immediately before testing. The study 
was performed on cameras: Mediso Nucline AP, Infinia Hawkeye 2 
and Infinia Hawkeye 4, equipped with low-energy, general purpose 
collimators (LEGP). During the test, a patient was placed in a supine 
position. Gamma camera detector was positioned under the pa-
tient with the field of view including both the kidneys and the heart. 
The study was started at the time of intravenous administration of 
111 MBq (3 mCi) of 99mTc-EC, collecting 60 twenty-second images in 
matrix 64 × 64 during 20 minutes.
Scintigraphic data processing was performed by drawing 
regions of interest (ROI) including the heart, the entire kidney, 
the renal parenchyma (possibly excluding the pelvis and calices) 
and area between the kidneys (blood background). The ROI for 
the whole kidney was determined by isocontour at 20% of the 
maximum counts on the summed images recorded between 2nd 
and 3rd minute of the study. Other ROIs were drawn manually: 
for heart — on the first registered image, for renal parenchyma 
— on summed images from between 14th and 15th minute of 
the study (avoiding calices and pelvis visible in these images). 
Then, time-activity curves were drawn for each ROI. Curves were 
smoothed with a three-point filter with 1–2–1 weight coefficients. 
Blood background curve was subtracted from the curves for the 
whole kidney and renal parenchyma (after correction due to ROI 
size). From these curves, MTT and PTT were determined using the 
matrix algorithm deconvolution.
In order to assess intra- and interobserver reproducibility of 
determined values of MTT and PTT, scintigraphic data were pro-
cessed independently by two operators: 
 — more experienced (A) — twice, with time interval of about two 
weeks, resulting in two pairs of MTT and PTT for each kidney 
(MTTA1 and PTTA1, and MTTA2 and PTTA2); 
 — less experienced (B) — once (MTTB and PTTB).
To establish normative values of determined parameters, the 
value obtained by the operator A in the first study was taken.
Statistical analysis: Assessments of the intra- and interobserver 
reproducibility were based on a comparison of the mean values of 
the studied variables (MTT and PTT) obtained by the operator A in 
the two studies (MTTA1 with MTTA2 and PTTA1 with PTTA2) — for in-
traobserver reproducibility, or obtained from the first study by the 
operator A and the study by the operator B (MTTA1 with MTTB and 
PTTA1 with PTTB) — for interobserver reproducibility. For this pur-
pose Student’s t-test for pairs was applied (normality of distribu-
tions was verified with Shapiro-Wilk’s test). In addition to statistical 
significance, practical significance of observed differences was also 
assessed, using Cohen’s d-coefficient, which is a measure of the 
effect size, that is — the difference between two mean values of 
MTT or PTT from different studies divided by a standard deviation 
for the data. {Formula: d = (M1 – M2)/SDpooled, where M1 is the 
mean value of MTTA1 or PTTA1, M2 is the mean value of MTTA2 or 
PTTA2 for intraobserver, and MTTB or PTTB for interobserver repro-
ducibility, respectively; while SDpooled is the standard deviation for 
the samples (SDpooled = √[(SD1
2+SD2
2)/2])}.
It is assumed that d > 0.8 indicates significant differences, 
0.5–0.8 — medium, 0.2–0.5 — small, and < 0.2 means that the 
differences are practically trivial. As an additional measurement 
of assessment reliability, linear correlation coefficients were ap-
plied, similarly for the results obtained in the two studies of the 
same operator in case of intraobserver reproducibility, and the 
results obtained by two independent operators for interobserver 
reproducibility. 
Statistical analysis was performed with Statistica 10.0 software.
Results
Basic parameters of distributions of MTT and PTT values ob-
tained by each of the operators are summarized in Table 1. There 
were no statistically significant differences between mean values of 
MTT and PTT from two studies by operator A (respectively p = 0.87 
and p = 0.36). The mean difference between the results did not 
exceed 1s. Cohen’s d-coefficients for MTT and PTT were d = 0.03 
and d = 0.05, respectively.
On the other hand, MTT and PTT obtained by operators A and 
B differed significantly (p = 0.02 and p < 0.001, respectively). The 
mean difference between the results was 4s for MTT and 14s for 
PTT. Cohens d-coefficients for MTT and PTT amounted to d = 0.16 
and d = 0.77, respectively.
Linear correlation coefficients between MTT and PTT val-
ues from two studies by operator A were r = 0.99 (Figure 1A) and 
r = 0.97 (Figure 1B), respectively, while for the pairs of values for 
MTT and PTT obtained by two operators – r = 0.93 (Figure 1C) 
and r = 0.81 (Figure 1D), respectively.
Normative values for MTT and PTT for normal kidneys were 
determined based on the first study performed by operator A. Their 
Table 1. Values of basic parameters describing distribution of results acquired by both operators




MTTA1 111 214 149 26 201
MTTA2 105 218 148 26 200 MTTA1 vs MTTA2 0.87 0.03
MTTB 97 208 145 25 195 MTTA1 vs MTTB 0.02 0.16
PTTA1 80 171 128 21 169 PTTA1 vs PTTA2 0.36 0.05
PTTA2 81 176 129 21 170 PTTA1 vs PTTB < 0.001 0.77
PTTB 86 150 114 15 145
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upper limits were determined as mean values plus two standard 
deviations (rounded), that is for MTT: (149 + 2 × 26) s ≈ 200 s, 
and for PTT: (128 + 2 × 21) s ≈ 170 s.
Discussion
Lack of significant differences between the mean values of 
MTT and PTT, and their close correlation in studies performed by 
the same operator (Figure 1A and 1B) give grounds to consider 
the processing procedure of dynamic renal scintigraphy used in 
this work to have high intraobserver reproducibility.
In case of studies performed by two operators, there were 
statistically significant differences between the mean values of the 
results. However, for MTT, these differences had no practical signifi-
cance (d < 0.2). Therefore, our method can be considered to have 
high interobserver reproducibility in this field, which is confirmed by 
a close correlation between pairs of MTT values obtained by both 
operators (Figure 1C).
The results were different in case of PTT values obtained by 
both operators. Their mean values show statistically significant dif-
ferences with medium size of effect (d = 0.77) and the correlation 
results were not as strict as in the case of MTT, although they were 
still high (r = 0.81, Figure 1D). This suggests that interobserver 
reproducibility is slightly lower in this field. These differences, how-
ever, do not disqualify the processing methods of dynamic renal 
scintigraphy.
High reproducibility of the results obtained by both operators for 
the MTT and the differences between the results obtained by 
these operators for PTT, can be explained by different methods of 
determining regions of interest for the whole kidney and its paren-
chyma (Figure 2). Whole kidney ROIs (for determining MTT) were 
drawn with isocontour with a constant value of 20% of the maxi-
mum number of counts in the kidney. This method of determining 
ROIs is strictly defined and reproducible. Only small, ischemic or 
Figure 1. Correlations between values obtained by the same operator in two studies for (A) MTT and (B) PTT — intraobserver reproducibility; and 
correlations between values obtained by both operators; (C) MTT and (D) PTT — interobserver reproducibility
Figure 2A. ROI for MTT, selected with isocontour with constant value 
of 20% maximum counts; B. ROI for PTT, selected manually
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cystic kidneys may cause some problems. On the other hand, 
parenchymal ROIs (for determining PTT) were drawn manually, so 
subjective factors could have a significant impact on their shape. 
Depending on the size of the selected area, it can for example 
contain smaller or larger share of calices, and that can change 
the value of determined parameter. Further efforts are necessary 
to minimize the impact of subjective elements in determination of 
parenchymal ROIs, by either standardization or automatization of 
the methods of selecting the ROI. Similar solution was also sug-
gested by Bergmann et al. [33].
Because of the fact that the results of MTT and PTT had high 
inter- and intraobserver reproducibility (even in case of PTT), they 
can be used as a basis for determining the upper limits of normative 
values for these parameters for normally functioning kidneys. Taking 
into account the values obtained by a more experienced operator 
in the first study, the upper limit of normal range was assumed to 
be 200 s for MTT and 170 s for PTT.
In Table 2, mean values of normal MTT and PTT obtained in our 
work were compared with those obtained by different authors for 
other radiopharmaceuticals in kidneys considered functionally ef-
ficient. It is apparent that mean values of MTT obtained in this work 
are lower than values obtained both by Piepsz et al. [25] and Rajabi 
et al. [17] for 99mTc-DTPA, as well as those calculated by Russell et 
al. [3] and Gonzales et al. [28] for 99mTc-MAG3. On the other hand, 
they are comparable with values reported by Kenny et al. [24] for 
131I-OIH. The mean values of PTT are also lower than those found 
in literature for 99mTc-DTPA [17] and 99mTc-MAG3 [3, 28]. It is also 
notable that Gupta et al. [29] obtained surprisingly high normative 
values of PTT for 99mTc-EC (in 5 healthy volunteers determined PTT 
was from 125 s to 206 s, on average — 175 s). Differences between 
MTT and PTT obtained in this work for 99mTc-EC and values of these 
parameters for other radiopharmaceuticals may result both from 
methodological factors and different mechanisms of their extraction 
in nephrone. 99mTc-DTPA is a subject only to glomerular filtration. 
99mTc-MAG3 is also excreted in only one mechanism — tubular se-
cretion. 131I-OIH on the other hand, is a subject to both glomerular 
filtration and tubular secretion, just like 99mTc-EC, which can explain 
similar MTT values obtained for these radiopharmaceuticals.
Conclusions
Obtained results justify the opinion that the procedure of pro-
cessing dynamic renal scintigraphy studies used in this research 
to determine the values of MTT and PTT gives reproducible results. 
Normative values of transit times for 99mTc-EC through the whole 
kidney and its parenchyma were determined as 200 s and 170 s, 
respectively. An attempt to optimize and standardize the tech-
nique of determining parenchymal ROI in a matrix deconvolution 
method, followed by an evaluation of clinical usefulness of these 
para meters in the diagnostics of chosen renal function impair-
ments would be a logical continuation of this initial research.
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